{"id":305071,"date":"2020-10-16T10:34:08","date_gmt":"2020-10-16T08:34:08","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=305071"},"modified":"2020-10-16T10:34:08","modified_gmt":"2020-10-16T08:34:08","slug":"szo-remdesivir-i-hidroksihlorokin-nisu-efikasni-u-lijecenju-covid19","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2020\/10\/16\/szo-remdesivir-i-hidroksihlorokin-nisu-efikasni-u-lijecenju-covid19\/","title":{"rendered":"SZO: Remdesivir i hidroksihlorokin nisu efikasni u lije\u010denju COVID19"},"content":{"rendered":"<p>Studija o ljekovima sprovedena je u vi\u0161e od 30 zemalja, a na osnovu prou\u010davanja efekata terapije na ukupni mortalitet, pokretanje ventilacije i trajanje boravka u bolnici kod hospitalizovanih pacijenata, prenosi Tass.<\/p>\n<p>Mnoge zemlje, uklju\u010duju\u0107i i SAD, Japan, Ju\u017enu Koreju, Indiju, Izrael i Veliku Britaniju koriste ih u lije\u010denju virusa korona.<\/p>\n<p>Taj lijek prvenstveno je namijenjen lije\u010denju hepatitisa C i respiratornog sincicijskog virusa, a prou\u010davalo se i njegovo dejstvo pri lije\u010denju ebole, ali u tom slu\u010daju nije pokazao efikasnost.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Svjetska zdravstvena organizacija je saop\u0161tila danas da ljekovi remdesivir, hidroksihlorokin, lopinavir\/ritonavir i proizvodi interferona daju male ili nikakve rezultate u borbi protiv virusa COVID-19.<\/p>\n","protected":false},"author":1,"featured_media":285348,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-305071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/305071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=305071"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/305071\/revisions"}],"predecessor-version":[{"id":305072,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/305071\/revisions\/305072"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/285348"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=305071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=305071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=305071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}